It may result in groundbreaking discoveries, improvements in medical treatments, Improved patient encounters, and cost cost savings for healthcare vendors and patients alike.; this subsegment is anticipated to achieve approximately 50 % of prescription revenue in 2027 (Exhibit five). We attribute its 8 percent CAGR in earnings advancement to improv